Transforming the Treatment

Of Kidney Disease

Kidney disease is a public health crisis

More than 850 million people worldwide suffer from some form of kidney disease. This includes those with chronic kidney disease (CKD), which is when the kidneys are damaged and progressively fail, and acute kidney injury (AKI), which is a rapid loss of kidney function over a short period of time.


In the US alone, there are 37 million patients suffering from CKD vs. 17 million cancer patients


This is more than 20X the number of people with cancer (44 million) or HIV/AIDS (38 million) worldwide


This is 2X the number of diabetes patients (422 million)

1 in 5

Adults suffer from AKI during a hospital stay

Walden Biosciences is a completely different type of biotech company
Our science is changing the treatment of kidney disease for patients
Join us for a professional experience like no other
Latest News
Walden Biosciences Expands Research Collaboration with the University of Michigan
Walden Biosciences to Host Virtual Event on November 14, 2023 “Transforming the Treatment Landscape of Chronic Kidney Disease”
Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases